News Medical

Tufts researchers identify new vulnerabilities to combat persistent C. diff infections

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile - commonly known as C. diff - are a serious and persistent problem for patients and ...
Nasdaq

Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile ...

Acurx's Program in the Broader CDI Patient Population is Ready to Advance toPhase 3 International Clinical Trials Acurx previously announced that it had received positive regulatory guidance from the ...
EurekAlert!

Novel vaccine protects against C. diff disease and recurrence

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...
syracuse.com

Dear Doctor: Should people take probiotics after antibiotics, especially if they have C. diff?

DEAR DR. ROACH: I read your recent column about a person who was refusing antibiotics due to a fear of a Clostridioides difficile (C. diff) recurrence. I am interested in your thoughts regarding ...